Chongqing Zhifei Biological Products Co., Ltd. (SHE: 300122)

Market Cap	51.08B
Revenue (ttm)	46.73B
Net Income (ttm)	6.04B
Shares Out	2.39B
EPS (ttm)	2.52
PE Ratio	8.47
Forward PE	6.45
Dividend	0.80 (3.75%)
Ex-Dividend Date	Aug 8, 2024

Volume	10,044,869
Open	22.09
Previous Close	21.33
Day's Range	21.06 - 22.09
52-Week Range	21.06 - 70.27
Beta	0.78
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Chongqing Zhifei Biological Products

Chongqing Zhifei Biological Products Co., Ltd. engages in the research, development, manufacture, marketing, distribution, import, and export of vaccines and biological products in China. It also provides cold storage services. The company was founded in 2002 and is based in Chongqing, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 6,545
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300122

Financial Performance

In 2023, Chongqing Zhifei Biological Products's revenue was 52.92 billion, an increase of 38.30% compared to the previous year's 38.26 billion. Earnings were 8.07 billion, an increase of 7.04%.